By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Akrimax Pharmaceuticals 

11 Commerce Dr.
1st Floor, Suite #100
Cranford  New Jersey  07016  U.S.A.
Phone: 908-372-0506 Fax: n/a




Company News
Akrimax Pharmaceuticals To Present Results From Three New Clinical Studies At The 2016 American Thyroid Association Meeting 9/20/2016 10:36:42 AM
Akrimax Pharmaceuticals Announces Publication Of CONTROL Surveillance Project Results 1/7/2016 11:32:55 AM
Akrimax Pharmaceuticals Release: New Research Quantifies The Prevalence Of Factors Known To Adversely Affect The Treatment Of Hypothyroidism 10/21/2015 11:42:06 AM
Akrimax Pharmaceuticals Initiates CONTROL Patient Registry For Tirosint® (Levothyroxine Sodium) Capsules 7/29/2014 10:32:43 AM
Akrimax Pharmaceuticals Release: New Data Highlight Use of Tirosint® (levothyroxine sodium) Capsules in Patients With T4 Malabsorption Due to Gastric Disorders 6/21/2013 9:33:27 AM
Akrimax Pharmaceuticals Announced the Launch of Suprenza (Phentermine Hcl) Orally Disintegrating Tablets (ODT) for the Management of Exogenous Obesity 5/24/2012 11:01:08 AM
Akrimax Pharmaceuticals Appoints Donald C. Olsen President 8/4/2011 8:37:45 AM
Pfizer Inc. (PFE) to Buy Back Akrimax Pharmaceuticals Plant and Sell or Close it by 2013; 60 Workers to Lose Jobs 6/29/2011 6:56:00 AM
Akrimax Pharmaceuticals, Introduces NitroMist(R) (Nitroglycerin Lingual Aerosol) 400mcg/Spray 3/16/2011 8:27:18 AM
Akrimax Pharmaceuticals Appoints Neil Larimer as Vice President Business Development & Manufacturing Alliances 5/6/2010 9:10:36 AM